-
Featured
Patient-derived Dopamine Neurons Show Promise in Parkinson's Treatment
Massachusetts General Hospital and McClean Hospital researchers take significant steps towards proving the safety and efficacy of dopaminergic neuron implantation to treat Parkinson's disease.
-
Featured
First-In-Human Therapy with Stem Cell–derived Dopaminergic Progenitor Cells for Parkinson's Disease
Mass General researchers report substantial clinical improvement in a patient with Parkinson's disease after they implanted midbrain dopaminergic progenitor cells that they differentiated in vitro from autologous induced pluripotent stem cells.
-
Featured
Collaboration in Developing New Cell Therapy
In this video, Bob S. Carter, MD, PhD, Kwang-Soo Kim, PhD, Todd M. Herrington, MD, PhD, and Jeffrey S. Schweitzer, MD, PhD, discuss their cross-disciplinary and multi-institutional collaboration to develop this new therapy.
-
Timing of Activity in the Basal Ganglia Is More Important to Movement than Firing Rates
Intraoperative electrophysiological data from patients with Parkinson's disease show that just prior to movement on a handgrip task, there was elevated subthalamic nucleus spike-to-cortical gamma phase coupling that preceded faster reaction times.
-
Treating Movement Disorders in Geriatric Populations: Q&A With Nicte Mejia, MD, MPH
Movement disorders can occur anytime across our lifespan. Tremor is the most common while Parkinson's disease increases as people age. Other movement disorders include tremor, dystonia, myoclonus and ataxia.
-
Using Stem Cells to Treat Movement Disorders
In this video, JeffreySchweitzer, MD, PhD, discusses his research using stem cell technology to restore normal function in patients with movement disorders. He believes this technology may be able to improve outcomes for patients with tremor, Parkinson's disease and dystonia.
Parkinsons Disease contributors
-
Bob S. Carter, MD, PhD
Chief, Neurosurgery Service
Recent Article
Patient-derived Dopamine Neurons Show Promise in Parkinson's Treatment
-
Ghazaleh Sadri-Vakili, MS, PhD
Assistant in Neuroscience, Massachusetts General Hospital, Assistant Professor of Neurology, Harvard Medical School
Recent Article
Cromolyn Sodium Provides Neuroprotection in Animal Model of ALS
-
Jeffrey S. Schweitzer, MD, PhD
Neurosurgeon
Recent Article
Patient-derived Dopamine Neurons Show Promise in Parkinson's Treatment
-
Michael D. Fox, MD, PhD
Associate Professor of Neurology, Harvard Medical School, Director, Laboratory for Brain Network Imaging and Modulation, Harvard Medical School, Assistant Neuroscientist, Massachusetts General Hospital
Recent Article
Lesion Locations Causing Cervical Dystonia Are Part of a Common Brain Network -
Robert (Mark) Richardson, MD, PhD
Director of Functional Neurosurgery, Massachusetts General Hospital
Recent Article
Timing of Activity in the Basal Ganglia Is More Important to Movement than Firing Rates -
Todd M. Herrington, MD, PhD
Director, Deep Brain Stimulation Program, Massachusetts General Hospital
Recent Article
Patient-derived Dopamine Neurons Show Promise in Parkinson's Treatment
-
Ziv Williams, MD
Associate Professor in Neurosurgery
Recent Article
Spine Surgeon Specialty Does Not Influence Short-term Outcomes of Percutaneous Kyphoplasty
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.Resource Links
